Carolina Wealth Advisors’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$19.7K Sell
156
-35,625
-100% -$4.69M 0.01% 159
2026
Q1
$4.99M Buy
35,781
+32,219
+905% +$4.51M 2.08% 8
2025
Q4
$437K Buy
3,562
+1,394
+64% +$169K 0.19% 57
2025
Q3
$241K Buy
2,168
+1,189
+121% +$135K 0.1% 70
2025
Q2
$109K Buy
979
+839
+599% +$89.3K 0.05% 69
2025
Q1
$15.7K Buy
140
+65
+87% +$6.71K 0.01% 121
2024
Q4
$6.93K Hold
75
﹤0.01% 162
2024
Q3
$6.29K Hold
75
﹤0.01% 207
2024
Q2
$5.15K Hold
75
﹤0.01% 167
2024
Q1
$5.49K Hold
75
﹤0.01% 168
2023
Q4
$6.08K Hold
75
﹤0.01% 176
2023
Q3
$5.62K Hold
75
﹤0.01% 184
2023
Q2
$5.78K Hold
75
﹤0.01% 175
2023
Q1
$6.22K Hold
75
﹤0.01% 167
2022
Q4
$6K Hold
75
﹤0.01% 163
2022
Q3
$5K Hold
75
﹤0.01% 171
2022
Q2
$5K Hold
75
﹤0.01% 194
2022
Q1
$4K Hold
75
﹤0.01% 214
2021
Q4
$5K Hold
75
﹤0.01% 209
2021
Q3
$5K Hold
75
﹤0.01% 205
2021
Q2
$5K Hold
75
﹤0.01% 218
2021
Q1
$5K Hold
75
﹤0.01% 245
2020
Q4
$4K Hold
75
﹤0.01% 187
2020
Q3
$5K Buy
+75
New +$5.2K ﹤0.01% 167
2020
Q1
Sell
-34,814
Closed -$2.26M 179
2019
Q4
$2.26M Buy
+34,814
New +$2.27M 2.14% 23

Other funds holding GILD

Carolina Wealth Advisors's GILD Position: Q2 2026 in Review

Carolina Wealth Advisors reduced its Gilead Sciences (GILD) stake by 100% in Q2 2026, selling an estimated $4.69M and leaving 156 shares worth $19.7K. The position accounts for 0.01% of the portfolio, ranked #159.

Carolina Wealth Advisors first reported a position in GILD in Q4 2019 and has held it in 25 quarters since. The position peaked at $4.99M in Q1 2026. 361 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Carolina Wealth Advisors held 156 shares of Gilead Sciences worth $19.7K as of Q2 2026.
  • Carolina Wealth Advisors sold 35,625 Gilead Sciences shares in Q2 2026, an estimated $4.69M.
  • Gilead Sciences made up 0.01% of Carolina Wealth Advisors's portfolio in Q2 2026, its #159 holding.
  • Carolina Wealth Advisors first reported a position in Gilead Sciences in Q4 2019 and has held it in 25 quarters since.
  • Carolina Wealth Advisors's Gilead Sciences position peaked at $4.99M in Q1 2026.
  • 361 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Carolina Wealth Advisors's 13F filing for Q2 2026, filed 9 Jul 2026.